Leaflet CLARINASE 5mg / 120mg modified release tablets

Indicated for: nasal congestion; rhinitis

Route of administration: oral

Substance: loratadine + pseudoephedrine (antihistamine + adrenergic decongestant)

ATC: R01BA52 (Respiratory system | Nasal decongestants for systemic use | Sympathomimetics)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Loratadine + pseudoephedrine is a combination medication used to treat symptoms of seasonal allergic rhinitis accompanied by severe nasal congestion. This combination combines the effects of an antihistamine and a decongestant:

- Loratadine is a second-generation antihistamine that blocks H1 histamine receptors, reducing allergy symptoms such as sneezing, itching, and nasal discharge.
- Pseudoephedrine is a decongestant that works by constricting blood vessels in the nasal mucosa, reducing congestion and improving breathing.

This combination is indicated for patients who experience both allergy symptoms and nasal congestion, providing comprehensive symptom relief.

Side effects may include dry mouth, dizziness, insomnia, palpitations, nervousness, or, in rare cases, severe allergic reactions. It is important to take the medication as prescribed by a doctor, and patients with high blood pressure, cardiovascular diseases, or other chronic conditions should consult their doctor before use.

General data about CLARINASE 5mg / 120mg

  • Substance: loratadine + pseudoephedrine
  • Date of latest medicines list: 01-06-2026
  • Product code: W62181006
  • Concentration: 5mg / 120mg
  • Pharmaceutical form: modified release tablets
  • Quantity: 14
  • Product type: Original
  • Price: 27.60 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: SAG MANUFACTURING S.L.U. - SPANIA
  • Holder: BAYER S.R.L. - ROMANIA
  • Number: 2360/2010/04
  • Shelf life: 2 years

Compensation lists for CLARINASE 5mg / 120mg Bayer

C3 - Sublist C - section C3 (children, pregnant women and postpartum women) with 100% discount from the reference price

Price

Copayment

Patient

27.60 RON

27.60 RON

0.00 RON